HHLR ADVISORS, LTD.
Institutional investor · Portfolio as of Q3 2019
Top Holdings64 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
IQIYI INC | 50.5M | $814.8M | 11.2% | $18.39 | -9.69% | 4 qtrssince 2018-Q4 | Increased 99 |
BEIGENE LTD-ADR | 5.5M | $670.1M | 9.2% | $134.02 | -9.28% | 4 qtrssince 2018-Q4 | Increased 74 |
TAL ED GROUP | 14.2M | $487.2M | 6.7% | $30.74 | +9.87% | 4 qtrssince 2018-Q4 | Increased 74 |
JD.COM INC-ADR | 16.1M | $454.7M | 6.3% | $20.17 | +25.14% | 4 qtrssince 2018-Q4 | Increased 62 |
UBER TECHNOLOGIES INC | 12.3M | $375.6M | 5.2% | $30.29 | 0.00% | 1 qtr | New 96 |
SEA LTD-ADR | 12M | $370.1M | 5.1% | $27.94 | +8.88% | 3 qtrssince 2019-Q1 | Increased 97 |
ALIBABA GROUP HOLDING-SP ADR | 2.2M | $364.3M | 5.0% | $138.98 | +13.24% | 4 qtrssince 2018-Q4 | Increased 85 |
PDD HOLDINGS INC | 11.1M | $359.1M | 4.9% | $25.15 | +24.38% | 4 qtrssince 2018-Q4 | Increased 80 |
ENSTAR GROUP LIMITED | 1.7M | $332M | 4.6% | — | — | 3 qtrssince 2019-Q1 | Increased 92 |
CHINA BIOLOGIC PRODS HLDGS I | 2.8M | $314.9M | 4.3% | — | — | 4 qtrssince 2018-Q4 | Unchanged 0 |
| 2.8M | $305.8M | 4.2% | — | — | — | Increased 82 | |
ALIGN TECHNOLOGY INC | 1.6M | $283.2M | 3.9% | $175.84 | 0.00% | 1 qtr | New 85 |
META PLATFORMS INC-CLASS A | 1.3M | $228.1M | 3.1% | $166.35 | +5.72% | 3 qtrssince 2019-Q1 | Increased 61 |
BILIBILI INC-SPONSORED ADR | 12.8M | $181.2M | 2.5% | $15.50 | -7.53% | 4 qtrssince 2018-Q4 | Increased 75 |
MONDELEZ INTERNATIONAL INC-A | 2.5M | $140.9M | 1.9% | $33.70 | +40.95% | 4 qtrssince 2018-Q4 | Unchanged 0 |
Kyntra Bio, Inc. | 3.5M | $129.6M | 1.8% | — | — | — | — |
APELLIS PHARMACEUTICALS INC | 4.7M | $112.7M | 1.5% | $18.73 | +30.41% | 4 qtrssince 2018-Q4 | Increased 73 |
BLUEPRINT MEDICINES CORP | 1.5M | $110.1M | 1.5% | — | — | 4 qtrssince 2018-Q4 | Unchanged 0 |
GOSSAMER BIO INC | 5.9M | $99.3M | 1.4% | $17.90 | -3.97% | 3 qtrssince 2019-Q1 | Increased 76 |
BRIDGEBIO PHARMA INC | 4.4M | $94.2M | 1.3% | $23.80 | -15.41% | 2 qtrssince 2019-Q2 | Increased 73 |
HHLR ADVISORS, LTD. manages $7.3B across 64 positions as of Q3 2019. Top holdings: IQ (11.2%), ONC (9.2%), TAL (6.7%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.
Active quarter - 25 new positions, 4 exits, 24 increased. Top move: IQ (INCREASED, conviction 99). Portfolio: $7.3B across 64 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer